Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US6485748 | COVIS | Once daily pharmaceutical tablet having a unitary core |
Dec, 2017
(6 years ago) | |
US5916595 | COVIS | HMG co-reductase inhibitor |
Dec, 2017
(6 years ago) | |
US6080778 | COVIS | Methods for decreasing beta amyloid protein |
Mar, 2018
(6 years ago) |
Market Authorisation Date: 26 June, 2002
Treatment: Method of decreasing the production of a-beta using a composition which decreases blood cholesterol in patients at risk of or exhibiting symptoms of alzheimer's disease
Dosage: TABLET, EXTENDED RELEASE;ORAL